Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.73
-0.17 (-4.36%)
At close: Aug 15, 2025, 12:44 PM
Perspective Therapeutics Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 234K | 342K | n/a | n/a | n/a | n/a | 337K | 1.91M | 1.5M | 1.83M | 1.83M | 1.72M | 2.5M | 2.91M | 2.82M | 2.56M | 2.71M | 2.6M |
Cost of Revenue | 709K | 732K | n/a | n/a | n/a | n/a | n/a | 1.45M | 1.84M | 1.58M | 1.43M | 1.3M | 1.58M | 1.47M | 1.6M | 1.53M | 1.36M | 1.24M |
Gross Profit | -475K | -390K | n/a | n/a | n/a | n/a | 337K | 462K | -340K | 254K | 403K | 414K | 926K | 1.44M | 1.22M | 1.03M | 1.35M | 1.36M |
Operating Income | -20.89M | -21.83M | -44.98M | -18.63M | -14.26M | -13.01M | -7.81M | -10.53M | -11.37M | -11.21M | -3.2M | -4.21M | -2.11M | -1.21M | -1.64M | -2.27M | -1.09M | -766K |
Interest Income | 2.65M | 2.38M | 2.65M | 3.58M | 3.08M | 1.21M | 62K | 204K | 294K | 374K | 400K | 140K | 28K | 29K | 31K | 31K | 32K | 21K |
Pretax Income | -42.21M | -18.18M | -42.27M | -15.12M | -11.28M | -11.82M | -8.87M | -10.08M | -11.11M | -10.87M | -2.9M | -4.07M | -2.08M | -1.35M | -1.6M | -2.24M | -1.06M | -745K |
Net Income | -40.17M | -18.18M | -40.17M | -15.12M | -11.7M | -12.28M | -24.68M | -10.36M | -11.11M | -371K | -2.2M | -3.93M | -2.01M | -1.21M | -1.6M | -2.24M | -1.06M | -745K |
Selling & General & Admin | 8.25M | 7.84M | 8.25M | 6.97M | 5.51M | 5.88M | 1.69M | 5.55M | 5.98M | 7.83M | 2.99M | 3.91M | 2.24M | 2.27M | 2.32M | 2.6M | 1.97M | 1.76M |
Research & Development | 12.17M | 14.33M | 12.88M | 12.03M | 9.28M | 7.45M | 6.08M | 5.72M | 5.65M | 3.86M | 613K | 708K | 796K | 549K | 535K | 702K | 468K | 362K |
Other Expenses | n/a | -342K | 23.86M | n/a | n/a | -325K | -5.21M | n/a | 2K | -233K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.42M | 21.83M | 46.44M | 18.63M | 14.26M | 13.01M | 2.57M | 11M | 11.03M | 11.46M | 3.61M | 4.62M | 3.03M | 2.82M | 2.85M | 3.3M | 2.44M | 2.13M |
Interest Expense | -119K | 128K | -73K | 69K | 23K | 29K | 24K | 14K | 26K | 18K | 400K | 140K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -2.58M | 855K | 911K | 812K | 814K | 800K | 654K | 687K | 702K | 761K | 659K | 581K |
Cost & Expenses | 21.13M | 21.83M | 45.22M | 18.63M | 14.26M | 13.01M | 2.57M | 12.44M | 12.87M | 13.04M | 5.04M | 5.92M | 4.61M | 4.29M | 4.45M | 4.84M | 3.8M | 3.36M |
Income Tax Expense | -2.1M | n/a | -2.1M | n/a | -61K | n/a | 7.85M | 278K | -215K | -10.5M | -702K | -140K | -65K | -140K | -28K | -29K | -574K | -31K |
Shares Outstanding (Basic) | 70.67M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
Shares Outstanding (Diluted) | 70.67M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
EPS (Basic) | -0.57 | -0.25 | -0.57 | -0.21 | -0.18 | -0.25 | -0.45 | -0.19 | -0.2 | -0.01 | -0.04 | -0.07 | -0.04 | -0.02 | -0.03 | -0.04 | -0.02 | -0.01 |
EPS (Diluted) | -0.57 | -0.25 | -0.57 | -0.21 | -0.18 | -0.25 | -0.45 | -0.19 | -0.2 | -0.01 | -0.04 | -0.07 | -0.04 | -0.02 | -0.03 | -0.04 | -0.02 | -0.01 |
EBITDA | -41.5M | -17.32M | -43.96M | -14.38M | -10.68M | -11.44M | -8.58M | -9.81M | -11.08M | -10.65M | -3.1M | -4.21M | -2.11M | -1.38M | -1.64M | -2.21M | -1.09M | -762K |
EBIT | -42.21M | -18.05M | -42.34M | -15.05M | -11.25M | -11.79M | -8.85M | n/a | -11.37M | -11.21M | -3.2M | n/a | n/a | -1.21M | n/a | -2.27M | n/a | n/a |
Depreciation & Amortization | 709K | 732K | 721K | 669K | 570K | 346K | 262K | 259K | 245K | 554K | 98K | 68K | 65K | -169K | 60K | 59K | 42K | 36K |